Analyst
Guggenheim
Equibles does not estimate personal net worth.
Vamil Divan is recorded as Analyst at Guggenheim. Vamil Divan has spoken on 2 investor events across 2 companies, most recently for AbbVie Inc. on June 22, 2026. Those appearances were for AbbVie Inc. (ABBV) and Travere Therapeutics, Inc. (TVTX). The companies whose calls Vamil Divan spoke on are classified in the Healthcare sector.
“So maybe two of I could, one, just on the atopic dermatitis, maybe you touched on this at the beginning of the call, but just the presence of Renvoke and that indication, kind of how you think of the overlap between that and now what you're getting from Apogee, and do you have any concerns from an FTC perspective on…”
“Also, I know it's been a long process to get to here. I guess my question is really around sort of the patient population here, because you were, before today, you were already saying 30,000 patients.”
Guggenheim
Analyst
Source not stated
ABBV
Drug Manufacturers - General · Healthcare
